Patents by Inventor David Zarbatany
David Zarbatany has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12582466Abstract: The present invention relates to an ablation assembly to treat target regions of a tissue in organs comprising: an ablation catheter comprising an elongate shaft having a longitudinal main direction (X-X), said elongate shaft comprising at least a shaft distal portion, said shaft distal portion comprising a shaft distal portion distal end; said ablation catheter comprising an inner lumen arranged within the elongate shaft; said ablation catheter comprising a shaft ablation assembly fixedly disposed at said shaft distal portion, the shaft ablation assembly being configured to deliver both thermal energy for ablating said tissue and non-thermal energy for treating said tissue; at least a shape setting mandrel disposed within the ablation catheter, the shape setting mandrel being insertable within the inner lumen and removable from the inner lumen, wherein the shape setting mandrel is free to move in respect of the inner lumen avoiding any constraint with said shaft distal portion during the shape settingType: GrantFiled: March 3, 2022Date of Patent: March 24, 2026Assignee: Argá Medtech SAInventors: Randell L. Werneth, David Zarbatany, Ricardo David Roman
-
Patent number: 12569691Abstract: Atrial appendage occlusion devices and cardiac monitoring positioned within the left atrial appendage and/or left atrium. In some embodiments the devices include an anchoring portion adapted to anchor the device in place adjacent the left atrial appendage, the anchoring portion comprising distal deformable anchoring portion adapted to be deployed in the left atrial appendage and a proximal deformable anchoring portion being adapted to be deployed in the left atrium, a barrier element secured to the anchoring portion and adapted to cover the left atrial appendage when implanted, and adapted to prevent blood clots from passing through the barrier element, and a cardiac monitoring element secured to at least one of the anchoring portions, the monitoring element including one or more sensors within in the left atrial appendage and/or left atrium and adapted to monitor left atrial cardiac data.Type: GrantFiled: January 20, 2018Date of Patent: March 10, 2026Assignee: VENTRIMEND, INC.Inventors: Randell L. Werneth, David Zarbatany
-
Publication number: 20260054077Abstract: Atrial appendage occlusion devices and cardiac monitoring positioned within the left atrial appendage and/or left atrium. In some embodiments the devices include an anchoring portion adapted to anchor the device in place adjacent the left atrial appendage, the anchoring portion comprising distal deformable anchoring portion adapted to be deployed in the left atrial appendage and a proximal deformable anchoring portion being adapted to be deployed in the left atrium, a barrier element secured to the anchoring portion and adapted to cover the left atrial appendage when implanted, and adapted to prevent blood clots from passing through the barrier element, and a cardiac monitoring element secured to at least one of the anchoring portions, the monitoring element including one or more sensors within in the left atrial appendage and/or left atrium and adapted to monitor left atrial cardiac data.Type: ApplicationFiled: October 31, 2025Publication date: February 26, 2026Applicant: Ventrimend, Inc.Inventors: David Zarbatany, Randell Werneth
-
Patent number: 12402885Abstract: An occlusion device (20) includes a compliant balloon (5) including an inflation port (3) for filling and unfilling a fluid into and from a balloon chamber (26). A distal tip element (10) and a proximal base element (4) are disposed at distal and proximal sides (28B, 28A) of the balloon (5), respectively. An elongate actuating element (9) is disposed longitudinally slidable in a balloon lumen (6) forming a longitudinal passage (27) from the proximal side (28A) to the distal side (28B) of the balloon (5), connected to the distal tip element (10), and longitudinally moveable with respect to the proximal base element (4) so as to set a distance between the distal tip element (100 and the proximal base element (4). A locking mechanism (2) is configured to maintain, between the distal tip element (10) and the proximal base element (4), the distance set using the elongate actuating element (9).Type: GrantFiled: March 19, 2021Date of Patent: September 2, 2025Assignee: UNIVERSITÄT ZÜRICHInventors: Francesco Maisano, Andrea Guidotti, Idan Tobis, David Zarbatany
-
Publication number: 20250269190Abstract: Atrial appendage occlusion devices and cardiac monitoring positioned within the left atrial appendage and/or left atrium. In some embodiments the devices include an anchoring portion adapted to anchor the device in place adjacent the left atrial appendage, the anchoring portion comprising distal deformable anchoring portion adapted to be deployed in the left atrial appendage and a proximal deformable anchoring portion being adapted to be deployed in the left atrium, a barrier element secured to the anchoring portion and adapted to cover the left atrial appendage when implanted, and adapted to prevent blood clots from passing through the barrier element, and a cardiac monitoring element secured to at least one of the anchoring portions, the monitoring element including one or more sensors within in the left atrial appendage and/or left atrium and adapted to monitor left atrial cardiac data.Type: ApplicationFiled: May 6, 2025Publication date: August 28, 2025Applicant: Ventrimend, Inc.Inventors: David Zarbatany, Randell Werneth
-
Publication number: 20250269191Abstract: Atrial appendage occlusion devices and cardiac monitoring positioned within the left atrial appendage and/or left atrium. In some embodiments the devices include an anchoring portion adapted to anchor the device in place adjacent the left atrial appendage, the anchoring portion comprising distal deformable anchoring portion adapted to be deployed in the left atrial appendage and a proximal deformable anchoring portion being adapted to be deployed in the left atrium, a barrier element secured to the anchoring portion and adapted to cover the left atrial appendage when implanted, and adapted to prevent blood clots from passing through the barrier element, and a cardiac monitoring element secured to at least one of the anchoring portions, the monitoring element including one or more sensors within in the left atrial appendage and/or left atrium and adapted to monitor left atrial cardiac data.Type: ApplicationFiled: May 6, 2025Publication date: August 28, 2025Applicant: Ventrimend, Inc.Inventors: David Zarbatany, Randell Werneth
-
Patent number: 12290694Abstract: Atrial appendage occlusion devices and cardiac monitoring positioned within the left atrial appendage and/or left atrium. In some embodiments the devices include an anchoring portion adapted to anchor the device in place adjacent the left atrial appendage, the anchoring portion comprising distal deformable anchoring portion adapted to be deployed in the left atrial appendage and a proximal deformable anchoring portion being adapted to be deployed in the left atrium, a barrier element secured to the anchoring portion and adapted to cover the left atrial appendage when implanted, and adapted to prevent blood clots from passing through the barrier element, and a cardiac monitoring element secured to at least one of the anchoring portions, the monitoring element including one or more sensors within in the left atrial appendage and/or left atrium and adapted to monitor left atrial cardiac data.Type: GrantFiled: April 21, 2022Date of Patent: May 6, 2025Assignee: Ventrimed IncInventors: David Zarbatany, Randell Werneth
-
Publication number: 20250073476Abstract: Atrial appendage occlusion devices and cardiac monitoring positioned within the left atrial appendage and/or left atrium. In some embodiments the devices include an anchoring portion adapted to anchor the device in place adjacent the left atrial appendage, the anchoring portion comprising distal deformable anchoring portion adapted to be deployed in the left atrial appendage and a proximal deformable anchoring portion being adapted to be deployed in the left atrium, a barrier element secured to the anchoring portion and adapted to cover the left atrial appendage when implanted, and adapted to prevent blood clots from passing through the barrier element, and a cardiac monitoring element secured to at least one of the anchoring portions, the monitoring element including one or more sensors within in the left atrial appendage and/or left atrium and adapted to monitor left atrial cardiac data.Type: ApplicationFiled: September 17, 2024Publication date: March 6, 2025Applicant: Ventrimend, Inc.Inventors: David Zarbatany, Randell Werneth
-
Patent number: 12090331Abstract: Atrial appendage occlusion devices and cardiac monitoring positioned within the left atrial appendage and/or left atrium. In some embodiments the devices include an anchoring portion adapted to anchor the device in place adjacent the left atrial appendage, the anchoring portion comprising distal deformable anchoring portion adapted to be deployed in the left atrial appendage and a proximal deformable anchoring portion being adapted to be deployed in the left atrium, a barrier element secured to the anchoring portion and adapted to cover the left atrial appendage when implanted, and adapted to prevent blood clots from passing through the barrier element, and a cardiac monitoring element secured to at least one of the anchoring portions, the monitoring element including one or more sensors within in the left atrial appendage and/or left atrium and adapted to monitor left atrial cardiac data.Type: GrantFiled: April 19, 2023Date of Patent: September 17, 2024Assignee: VENTRIMEND, INC.Inventors: David Zarbatany, Randell Werneth
-
Publication number: 20240041603Abstract: A leaflet restraint (20) includes a non-blood-occlusive net (30), which is configured to at least partially cover an atrial surface (32) of a single native cardiac leaflet (34) of a native atrioventricular valve (36) of a heart (38). Two or more tissue-penetrating annulus anchors (40) are fixed to an annular side (42) of the net (30), and are configured to be anchored to an annulus (44) of the native atrioventricular valve (36) along or within 1 cm of a portion of the annulus (44) to which the single native cardiac leaflet (34) attaches. A ventricular anchor (50) is configured to be anchored to a ventricle (54) of the heart (58) so as to anchor a ventricular end (52) of the net (30) to the ventricle (54). The leaflet restraint (20) is configured, when anchored in place at least partially covering the atrial surface (32) of the single native cardiac leaflet (34), to limit prolapse of the single native cardiac leaflet (34) into an atrium (56) of the heart (38). Other embodiments are also described.Type: ApplicationFiled: December 9, 2021Publication date: February 8, 2024Applicant: SV SWISSVORTEX AGInventors: Andrea GUIDOTTI, David ZARBATANY, Pietro GOZZOLI
-
Publication number: 20230390057Abstract: A split-frame cardiac valve (20) is configured to assume a radially compressed configuration for transcatheter delivery and a radially expanded configuration for anchoring to a native cardiac valve annulus. The split-frame cardiac valve (20) includes circumferential frame segments (22) including respective stents (24) and prosthetic leaflets (30). When the split-frame cardiac valve (20) is in the radially expanded configuration: (a) each of the stents (24) surrounds less than 360 degrees of a central longitudinal axis (26) of the split-frame cardiac valve (20), (b) the circumferential frame segments (22) are slidingly coupled to one another so as to be axially slidable with respect to one another in and out of axial alignment with one another, and (c) when the circumferential frame segments (22) are axially aligned with one another, the stents (24) collectively define a tubular stent (32) that entirely surrounds the central longitudinal axis (26).Type: ApplicationFiled: June 9, 2023Publication date: December 7, 2023Applicant: Open Stent Solution SASInventors: Andrea Guidotti, David Zarbatany, Ricardo Roman, Georgios Stefopoulos, Pietro Gozzoli
-
Publication number: 20230346538Abstract: Auxiliary components for medical devices, and more specifically, sensing constructs that may be added to a medical device such as an implantable medical device to provide the medical device with sensing functionality. The auxiliary component is not a part of the medical device, but rather is associated with an existing medical device in a secure manner, and provides information about the medical device and/or the environment around the medical device when the device is implanted in a patient, and then transmits that information to a location outside of the patient for evaluation. Delivery systems for delivering the auxiliary components.Type: ApplicationFiled: October 7, 2021Publication date: November 2, 2023Inventors: Mark A. Adler, Jeffrey M. Gross, William L. Hunter, Kimberly Salant, Peter J. Schiller, David Zarbatany
-
Publication number: 20230329853Abstract: A valve-delivery-assist tool (20, 120, 220, 320) is provided for use during a transcatheter aortic valve implantation (TAVI) procedure on a native aortic valve. The valve-delivery-assist tool (20, 120, 220, 320) includes a delivery catheter (22); an aortic-valve cusp guide (24), which deflects laterally upon being released from the delivery catheter (22); and a conduction-tissue protector (26, 126), which includes a sheet (28, 128) and expands upon being released from a distal end (29) of the delivery catheter (22).Type: ApplicationFiled: August 26, 2021Publication date: October 19, 2023Applicant: SV SWISSVORTEX AGInventors: Andrea GUIDOTTI, Idan TOBIS, David ZARBATANY, Pietro GOZZOLI, Ricardo ROMAN
-
Publication number: 20230320856Abstract: The present invention describes systems and methods for treating tricuspid valve regurgitation and mitral valve regurgitation. The treatment includes a systems and method of modifying the tricuspid or mitral valve by attaching a device in two locations in the valve annulus and pulling them toward each other to stop valve regurgitation by modifying the leaflets of the valve.Type: ApplicationFiled: February 6, 2023Publication date: October 12, 2023Applicant: Ventrimend, IncInventors: David Zarbatany, Ricardo Roman, Jesus Flores
-
Publication number: 20230248983Abstract: Atrial appendage occlusion devices and cardiac monitoring positioned within the left atrial appendage and/or left atrium. In some embodiments the devices include an anchoring portion adapted to anchor the device in place adjacent the left atrial appendage, the anchoring portion comprising distal deformable anchoring portion adapted to be deployed in the left atrial appendage and a proximal deformable anchoring portion being adapted to be deployed in the left atrium, a barrier element secured to the anchoring portion and adapted to cover the left atrial appendage when implanted, and adapted to prevent blood clots from passing through the barrier element, and a cardiac monitoring element secured to at least one of the anchoring portions, the monitoring element including one or more sensors within in the left atrial appendage and/or left atrium and adapted to monitor left atrial cardiac data.Type: ApplicationFiled: April 19, 2023Publication date: August 10, 2023Applicant: Ventrimend, Inc.Inventors: David Zarbatany, Randell Werneth
-
Publication number: 20230218340Abstract: The present invention relates to an ablation equipment (100) to treat target regions of tissue (41) in organs (44), comprising an ablation catheter (1) and a single power source (4); said ablation catheter (1) comprising: a catheter elongated shaft (13) comprising at least an elongated shaft distal portion (17); said catheter elongated shaft (13) comprising a flexible body (207) to navigate through body vessels (208); said ablation catheter (1) further comprising a shaft ablation assembly (20) disposed at said elongated shaft distal portion (17); said shaft ablation assembly (2) comprising at least a plurality of electrodes (127, 113 or 114) fixedly disposed at said elongated shaft distal portion (17); all electrodes of said at least a plurality (127, 113 or 114) being electrically powered by said single power source (4) through an electric signal (S) to deliver both non-thermal energy for treating the tissue (41) and thermal energy for ablating the tissue (41); wherein said electric signal (S) comprises a siType: ApplicationFiled: June 7, 2021Publication date: July 13, 2023Inventors: Randell L WERNETH, David ZARBATANY, Ricardo David ROMAN
-
Publication number: 20230218291Abstract: The present invention describes systems and methods for treating mitral valve regurgitation. The treatment includes a systems and method of modifying the mitral valve by attaching a device to each leaflet and pulling them toward each other to stop mitral valve regurgitation.Type: ApplicationFiled: February 6, 2023Publication date: July 13, 2023Applicant: Ventrimend, IncInventors: David Zarbatany, Ricardo Roman, Jesus Flores
-
Publication number: 20230200994Abstract: The present invention describes systems and methods for treating mitral valve regurgitation. The treatment includes a systems and method of modifying the mitral valve by attaching a device to each leaflet and pulling them toward each other to stop mitral valve regurgitation.Type: ApplicationFiled: November 30, 2022Publication date: June 29, 2023Applicant: Ventrimend, IncInventors: David Zarbatany, Ricardo Roman, Jesus Flores
-
Publication number: 20230048179Abstract: The present invention describes systems and methods for treating mitral valve regurgitation. The treatment includes a systems and method of modifying the mitral valve by attaching a device to each leaflet and pulling them toward each other to stop mitral valve regurgitation.Type: ApplicationFiled: August 14, 2022Publication date: February 16, 2023Applicant: Ventrimend, IncInventors: David Zarbatany, Ricardo Roman, Jesus Flores
-
Publication number: 20220401087Abstract: The present invention describes systems and methods for treating a hole in the septum, such as a patent foramen ovale or an atrial septal defect, with a closure implant designed to fluidly seal the hole to prevent blood from flowing between the right atrium to the left atrium. The closure implant includes two structures positioned on opposite sides of the hole in septum configured to close and seal the hole. The first structure is an expandable petal anchor having multiple petal groups with multiple petals of different sizes and/or shapes made of shape memory wire configured to be positioned on a distal side of the hole in the septum wall, and the second structure is a braided disk made of shape memory mesh positioned the proximal side of the hole in the septum wall, opposite the petal anchor. The braided disk is sized to cover the hole once it is expanded. The petal anchor is designed to pull and compress the braided disk against the septum wall to cover and fluidly seal the hole.Type: ApplicationFiled: June 22, 2022Publication date: December 22, 2022Applicant: Ventrimend, IncInventors: David Zarbatany, Ricardo Roman